Hotchkis & Wiley Capital Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.37M Buy
111,950
+10,310
+10% +$587K 0.02% 359
2025
Q1
$5.7M Buy
101,640
+26,460
+35% +$1.48M 0.02% 358
2024
Q4
$4.62M Sell
75,180
-13,830
-16% -$850K 0.02% 396
2024
Q3
$5.96M Buy
89,010
+50,030
+128% +$3.35M 0.02% 373
2024
Q2
$2.6M Buy
38,980
+3,360
+9% +$224K 0.01% 459
2024
Q1
$2.53M Buy
+35,620
New +$2.53M 0.01% 458